AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 Jun 14, 2022 AXIM BIOTECHNOLOGIES, INC - FORM S-8
10-Q May 23, 2022 FORM 10-Q
NT 10-Q May 17, 2022 AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q
10-K/A Apr 19, 2022 FORM 10-K/A
10-K Apr 15, 2022 FORM 10-K
NT 10-K Mar 31, 2022 AXIM BIOTECHNOLOGIES, INC. FORM 12B-25
8-K Mar 9, 2022 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
8-K Feb 16, 2022 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
4 Feb 15, 2022 PRIMARY DOCUMENT
8-K Jan 12, 2022 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
8-K Jan 7, 2022 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
10-Q Nov 22, 2021 AXIM FORM 10-Q
NT 10-Q Nov 15, 2021 AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q
10-Q Aug 23, 2021 AXIM BIOTECHNOLOGIES, INC. FORM 10-Q
NT 10-Q Aug 16, 2021 AXIM BIOTECHNOLOGIES, INC. FORM NT 10-Q
8-K Aug 4, 2021 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
EFFECT Jun 22, 2021
CORRESP Jun 21, 2021
S-1/A Jun 9, 2021 FORM S-1/A REGISTRATION STATEMENT
10-Q/A Jun 2, 2021 FORM 10-Q/A AMENDED QUARTERLY REPORT
10-Q May 24, 2021 FORM 10-Q QUARTERLY REPORT
UPLOAD May 19, 2021
NT 10-Q May 14, 2021 FORM NT 10-Q NOTICE OF LATE QUARTERLY FILING
S-1 May 14, 2021 FORM S-1 REGISTRATION STATEMENT
8-K May 14, 2021 FORM 8K CURRENT REPORT
← Newer Page 4 of 13 · 306 filings Older →